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according to Kerr index (≥2), and had also evidence of active disease at PET/CT. Table 1 summarizes the main results of our study. Despite RTX treatment, 4 of the 7 patients had evidence of persistent disease activity and/or radiographic disease progression during follow-up. Three out of 7 patients in whom RTX was employed as rescue therapy achieved complete remission. Conclusions: Our data do not support a role for RTX as first line biologic therapy in TAK patients, but it may have a role in some patients as second/third line biological therapy. Results: 15 patients, 6 males and 9 females (mean age 71.6±7 years -duration symptoms at onset 1.7±1.3 months -mean ESR 60 mm/h ±29 -mean CRP 8 mg/dl ± 5.2) entered the study. US halo sign was bilateral in 10/15 (66,7%). The mean halo thickness was 0.53 mm ± 0.12. Five patients had USG =1, six patients =2 and four patients =3. The hystological inflammatory grade 1 was present in seven pts, grade 2 in four and grade 3 in four pts. No significant correlation were found between USG and histological inflammatory grade, nor with the presence of giant cells, calcifications, laminar necrosis and intima-media thickness. Background: French general health insurance scheme has implemented a national influenza vaccination program, including full refund for those 65 years old or more. Despite this program, only 62.6 to 71% of people aged over 65 years are vaccinated and no data are available regarding influenza vaccination coverage (IVC) in GCA. Objectives: To evaluate the rate and the factors associated with seasonal influenza vaccination coverage in incident giant cell arteritis (GCA) patients compared with controls. Methods: Using the French National Health Insurance system (SNIIRAM), we included patients with incident GCA from the Midi-Pyrenees region, southern France, and randomly selected 6 controls matched by sex and age at calendar date from January 2005 to December 2008 and followed them till April 2011. The vaccination rate was estimated from vaccine dispensation registered in the SNIIRAM. IVC was compared between GCA and their controls using longitudinal multivariate Poisson regression. Results: Eighty-seven incident GCA patients over 65 years of age and 509 in the control group were included. Mean follow-up was 4.4±1.2 and 4.2±1.2 years, respectively. During the yearly influenza campaigns from 2005-2006 to 2010-2011 , the IVC rates in the GCA group and the control group ranged from 60.8 to 74.7% vs 56.6 to 70.4%, respectively. Incident GCA influenza vaccination rate was 20% higher than controls (RR=1.20; IC 1.09 to 1.32, P<0.001) ( Table  1) .
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